Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Published in: Calcified Tissue International 6/2010

01-12-2010 | Erratum

Erratum to: Risk of Upper Gastrointestinal Tract Events in Risedronate Users Switched to Alendronate

Authors: Stuart H. Ralston, Tzuyung D. Kou, Bettina Wick-Urban, Michael Steinbuch, Tahir Masud

Published in: Calcified Tissue International | Issue 6/2010

Login to get access

Excerpt

In the article by Ralston et al. (Calcif Tissue Int (2010) 87:298–304; DOI 10.1007/s00223-010-9401-0), it was incorrectly stated in the third paragraph of the results section on page 300 that “In total 30/530 (5.6%) patients who switched from alendronate to risedronate developed an upper GI event”. The correct text should read “In total 30/530 (5.6%) patients who switched from risedronate to alendronate developed an upper GI event”. This typographical error does not affect any of the data presented or the conclusions of the paper. …
Metadata
Title
Erratum to: Risk of Upper Gastrointestinal Tract Events in Risedronate Users Switched to Alendronate
Authors
Stuart H. Ralston
Tzuyung D. Kou
Bettina Wick-Urban
Michael Steinbuch
Tahir Masud
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 6/2010
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-010-9430-8

Other articles of this Issue 6/2010

Calcified Tissue International 6/2010 Go to the issue

OriginalPaper

Osteogenic Potential of Biosilica on Human Osteoblast-Like (SaOS-2) Cells

OriginalPaper

Lipid Profiles and Bone Mineral Density in Pre- and Postmenopausal Women in Korea

OriginalPaper

The Biphenyl-Carboxylate Derivative ABD328 is a Novel Orally Active Antiresorptive Agent

OriginalPaper

Normative Calcaneal Quantitative Ultrasound Data as an Estimation of Skeletal Development in Swedish Children and Adolescents

OriginalPaper

Muscle Changes Can Account for Bone Loss After Botulinum Toxin Injection

REVIEW

Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits